FDA approves gene therapy for rare neurological disorder
Drug Discovery World
SEPTEMBER 20, 2022
SKYSONA has become the first FDA approved therapy to slow the progression of neurologic dysfunction in boys with cerebral adrenoleukodystrophy (CALD). The post FDA approves gene therapy for rare neurological disorder appeared first on Drug Discovery World (DDW).
Let's personalize your content